110 related articles for article (PubMed ID: 11341477)
1. Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat.
Kuhmonen J; Haapalinna A; Sivenius J
J Neural Transm (Vienna); 2001; 108(3):261-71. PubMed ID: 11341477
[TBL] [Abstract][Full Text] [Related]
2. The role of phosphoinositide-3-kinase/Akt pathway in propofol-induced postconditioning against focal cerebral ischemia-reperfusion injury in rats.
Wang HY; Wang GL; Yu YH; Wang Y
Brain Res; 2009 Nov; 1297():177-84. PubMed ID: 19703434
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of treatment with low-dose gliclazide in a model of middle cerebral artery occlusion and reperfusion in rats.
Tan F; Li H; Ma M; Yu Y
Brain Res; 2014 Apr; 1560():83-90. PubMed ID: 24602692
[TBL] [Abstract][Full Text] [Related]
4. Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats.
Lukic-Panin V; Kamiya T; Zhang H; Hayashi T; Tsuchiya A; Sehara Y; Deguchi K; Yamashita T; Abe K
Brain Res; 2007 Oct; 1176():143-50. PubMed ID: 17904110
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of nobiletin on cerebral ischemia-reperfusion injury in transient middle cerebral artery-occluded rats.
Yasuda N; Ishii T; Oyama D; Fukuta T; Agato Y; Sato A; Shimizu K; Asai T; Asakawa T; Kan T; Yamada S; Ohizumi Y; Oku N
Brain Res; 2014 Apr; 1559():46-54. PubMed ID: 24534366
[TBL] [Abstract][Full Text] [Related]
6. Effects of dexmedetomidine on microregional O2 balance during reperfusion after focal cerebral ischemia.
Chi OZ; Grayson J; Barsoum S; Liu X; Dinani A; Weiss HR
J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):163-70. PubMed ID: 25294058
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment with melatonin exerts anti-inflammatory effects against ischemia/reperfusion injury in a rat middle cerebral artery occlusion stroke model.
Pei Z; Cheung RT
J Pineal Res; 2004 Sep; 37(2):85-91. PubMed ID: 15298666
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of immunosuppressant FK506 in transient focal ischemia in rat: therapeutic time window for FK506 in transient focal ischemia.
Arii T; Kamiya T; Arii K; Ueda M; Nito C; Katsura KI; Katayama Y
Neurol Res; 2001 Oct; 23(7):755-60. PubMed ID: 11680517
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine-induced cerebral hypoperfusion exacerbates ischemic brain injury in rats.
Nakano T; Okamoto H
J Anesth; 2009; 23(3):378-84. PubMed ID: 19685118
[TBL] [Abstract][Full Text] [Related]
10. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
[TBL] [Abstract][Full Text] [Related]
11. Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms.
Zausinger S; Hungerhuber E; Baethmann A; Reulen H; Schmid-Elsaesser R
Brain Res; 2000 Apr; 863(1-2):94-105. PubMed ID: 10773197
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of olprinone after cerebral ischemia/reperfusion injury in rats.
Genovese T; Mazzon E; Paterniti I; Esposito E; Cuzzocrea S
Neurosci Lett; 2011 Oct; 503(2):93-9. PubMed ID: 21872644
[TBL] [Abstract][Full Text] [Related]
13. Effect of the alpha2-agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats.
Engelhard K; Werner C; Kaspar S; Möllenberg O; Blobner M; Bachl M; Kochs E
Anesthesiology; 2002 Feb; 96(2):450-7. PubMed ID: 11818781
[TBL] [Abstract][Full Text] [Related]
14. Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T.
Barber PA; Hoyte L; Kirk D; Foniok T; Buchan A; Tuor U
Neurosci Lett; 2005 Nov; 388(1):54-9. PubMed ID: 16055267
[TBL] [Abstract][Full Text] [Related]
15. Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates.
Suzuki N; Suzuki M; Murakami K; Hamajo K; Tsukamoto T; Shimojo M
Brain Res; 2012 Jan; 1430():93-100. PubMed ID: 22119394
[TBL] [Abstract][Full Text] [Related]
16. Peripheral administration of carbenoxolone reduces ischemic reperfusion injury in transient model of cerebral ischemia.
Vakili A; Hosseinzadeh SA; Khorasani MZ
J Stroke Cerebrovasc Dis; 2009; 18(2):81-5. PubMed ID: 19251182
[TBL] [Abstract][Full Text] [Related]
17. Uridine 5'-triphosphate (UTP) protects against cerebral ischemia reperfusion injury in rats.
Tian ML; Zou Z; Yuan HB; Wang CC; Zhu QF; Xu HT; Gao X; Shi XY
Neurosci Lett; 2009 Nov; 465(1):55-60. PubMed ID: 19733210
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective activity of creatylglycine ethyl ester fumarate.
Veselkina OS; Morozov VA; Korzhevskii DE; Tihonov DB; Barygin OI; Isaeva AV; Portsel MN; Vlasov TD
J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):591-600. PubMed ID: 25561316
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of rhGLP-1 (7-36) on brain ischemia/reperfusion damage in diabetic rats.
Zhao L; Xu J; Wang Q; Qian Z; Feng W; Yin X; Fang Y
Brain Res; 2015 Mar; 1602():153-9. PubMed ID: 25601009
[TBL] [Abstract][Full Text] [Related]
20. A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats undergoing transient middle cerebral artery ischemia.
Seyfried DM; Veyna R; Han Y; Li K; Tang N; Betts RL; Weinsheimer S; Chopp M; Anagli J
Brain Res; 2001 May; 901(1-2):94-101. PubMed ID: 11368955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
